# Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival Display

> **NCT07715331** · NA · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 20 (actual)

## Conditions studied

- Excessive Gingival Display
- Gingival Diseases
- Gummy Smile
- Esthetics, Dental

## Interventions

- **DRUG:** Botulinum Toxin Type A (Refinex®)
- **DRUG:** Cross-Linked Hyaluronic Acid Filler (Juvéderm Voluma® with Lidocaine)

## Key facts

- **NCT ID:** NCT07715331
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715331, "Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival Display". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07715331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*